Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings (Q35016119)

5 August 2017

title

Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings (English)

1 reference

5 August 2017

1 reference

1 reference

Giorgia Mangili

1

1 reference

5 August 2017

Patrizia De Marzi

2

1 reference

5 August 2017

Saverio Beatrice

3

1 reference

5 August 2017

Emanuela Rabaiotti

4

1 reference

5 August 2017

Riccardo Viganò

5

1 reference

5 August 2017

Luigi Frigerio

6

1 reference

5 August 2017

Cinzia Gentile

7

1 reference

5 August 2017

Ferruccio Fazio

8

1 reference

5 August 2017

language of work or name

English

0 references

publication date

25 July 2006

1 reference

5 August 2017

1 reference

5 August 2017

volume

6

1 reference

5 August 2017

page(s)

198

1 reference

DNA ploidy analysis in histopathology. Morphometry and DNA cytometry reproducibility conditions and clinical applications

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Paclitaxel and concurrent radiation in upper gastrointestinal cancers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Advances in the management of endometrial adenocarcinoma. A review

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: first feasibility study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Disruption of microtubules in living cells by tyrphostin AG-1714.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Adjuvant chemotherapy for high-risk endometrial cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Chemotherapy as adjuvant and salvage treatment in women with endometrial carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Paclitaxel sensitizes multidrug resistant cells to radiation

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Adjuvant chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (PAC) for early-stage high-risk endometrial cancer: a preliminary analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study

8 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-198

Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-198

DNA ploidy is an independent prognostic indicator of overall survival in stage I endometrial endometrioid carcinoma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Carcinoma of the corpus uteri

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

[Adjuvant chemotherapy with cyclophosphamide, adriamycin, and CDDP (CAP) for high risk endometrial cancer after complete surgery].

25 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1559635

Cisplatin, doxorubicin and cyclophosphamide (PAC) followed by radiation therapy in high-risk endometrial carcinoma

25 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-198

Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-6-198

Paclitaxel and simultaneous radiation in the treatment of stage IIIA/B non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer

1 reference

12 December 2020

Taxol is active in platinum-resistant endometrial adenocarcinoma

1 reference

12 December 2020

Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium

1 reference

12 December 2020

Whole abdominal radiotherapy in the adjuvant treatment of patients with stage III and IV endometrial cancer: a gynecologic oncology group study

1 reference

12 December 2020

Cisplatin chemotherapy for disseminated endometrial cancer

1 reference

12 December 2020

Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer

1 reference

12 December 2020

The efficacy of postoperative vaginal irradiation in preventing vaginal recurrence in endometrial cancer

1 reference

12 December 2020

Improved outcome at 10 years for serous-papillary/clear cell or high-risk endometrial cancer patients treated by adjuvant high-dose whole abdomino-pelvic irradiation

1 reference

12 December 2020

Adjuvant chemotherapy including cisplatin in endometrial carcinoma

1 reference

12 December 2020

The effect of postsurgical therapy on stage III endometrial carcinoma

1 reference

12 December 2020

Phase II study of paclitaxel as salvage treatment in advanced endometrial cancer

1 reference

12 December 2020

Significant pelvic recurrence in high-risk pathologic stage I–IV endometrial carcinoma patients after adjuvant chemotherapy alone: implications for adjuvant radiation therapy

1 reference

12 December 2020

Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients

1 reference

12 December 2020

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

1 reference

12 December 2020

Preliminary analysis of RTOG 9708: adjuvant postoperative radiotherapy combined with cisplatin/paclitaxel chemotherapy after surgery for patients with high-risk endometrial cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-6-198

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference

5 August 2017

1 reference